Immunomodulatory Alpha Neutrophil product (IMANp)

N/A

Report date: 2024/01/09 14:48:04

Base Information

Drug NameImmunomodulatory Alpha Neutrophil product (IMANp)
Drug Alias NameNeutrophil only leukocyte infusion therapy (LIfT BioSciences)免疫调节性α中性粒细胞产品Allogeneic granulocyte therapy (LIfT BioSciences)N-LIfT
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionCell replacementsImmunologic cytotoxicity
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLift Biosciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLift Biosciences Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A